Positive Phase 1/2 Clinical Trial Data for an Investigational Gene Therapy for Genetic Hearing Loss to be Presented at … – Investors | Eli Lilly and…

Posted: January 28, 2024 at 2:42 am

Positive Phase 1/2 Clinical Trial Data for an Investigational Gene Therapy for Genetic Hearing Loss to be Presented at ...  Investors | Eli Lilly and Company

Read the original post:
Positive Phase 1/2 Clinical Trial Data for an Investigational Gene Therapy for Genetic Hearing Loss to be Presented at ... - Investors | Eli Lilly and...

Related Posts

Comments are closed.

Archives